Showing 1 - 3 results of 3 for search 'Jennifer M. Thomas-Ahner', query time: 0.02s Refine Results
  1. 1
    Prostate Cancer Cell Phenotypes Remain Stable Following PDE5 Inhibition in the Clinically Relevant Range

    Prostate Cancer Cell Phenotypes Remain Stable Following PDE5 Inhibition in the Clinically Relevant Range by William Hankey, Benjamin Sunkel, Fuwen Yuan, Haiyan He, Jennifer M. Thomas-Ahner, Zhong Chen, Steven K. Clinton, Jiaoti Huang, Qianben Wang

    Published 2020-09-01
    Get full text
    Article
  2. 2
    Inhibition of androgen/AR signaling inhibits diethylnitrosamine (DEN) induced tumour initiation and remodels liver immune cell networks

    Inhibition of androgen/AR signaling inhibits diethylnitrosamine (DEN) induced tumour initiation and remodels liver immune cell networks by Timothy H. Helms, Riley D. Mullins, Jennifer M. Thomas-Ahner, Samuel K. Kulp, Moray J. Campbell, Fabienne Lucas, Nathan Schmidt, Dana M. LeMoine, Surafel Getaneh, Zhiliang Xie, Mitch A. Phelps, Steven K. Clinton, Christopher C. Coss

    Published 2021-02-01
    Get full text
    Article
  3. 3
    Effects of a Group-Mediated Cognitive Behavioral Lifestyle Intervention on Select Social Cognitive Outcomes in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy

    Effects of a Group-Mediated Cognitive Behavioral Lifestyle Intervention on Select Social Cognitive Outcomes in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy by Brian C. Focht PhD, FACSM, CSCS, Alexander R. Lucas PhD, Elizabeth Grainger PhD, Christina Simpson BS, Ciaran M. Fairman PhD, Jennifer M. Thomas-Ahner PhD, Zachary L. Chaplow MS, Victoria R. DeScenza MS, Jessica Bowman MS, Steven K. Clinton MD, PhD

    Published 2019-12-01
    Get full text
    Article

Search Tools: